Skip to content

Sidley Awards & News

  • Select:

In This Issue

  • Select:

Femtech in the Spotlight:
An Interview with Wolfgang Hackl, Founder and CEO of OncoGenomX

Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.


If you have any questions regarding this issue of the Global Life Sciences Briefing or suggestions for topics to be covered in future issues, please contact the Sidley lawyer with whom you usually work, or Sidley Global Life Sciences.